Built on real lobbying data and peer-reviewed research. Adjust the inputs — see your estimated return in real time.
Derived from Senate LDA LD-2 filings (2008–2024) and peer-reviewed analysis of lobbying outcomes by industry. Multipliers represent estimated value generated per dollar spent, based on cross-referenced government spending and contract award data.
| Industry | Median Annual Spend (LDA) | Est. Return Multiplier | Primary Objective | ROI Strength |
|---|---|---|---|---|
| Pharmaceutical / Biotech | $2.4M | 8–14× | FDA approval, drug pricing, R&D credits | Exceptional |
| Defense & Aerospace | $4.1M | 6–11× | Contract awards, procurement policy | Exceptional |
| Energy & Utilities | $3.2M | 5–9× | Subsidies, permitting, emissions regulation | Strong |
| Finance & Banking | $1.8M | 5–8× | Tax legislation, regulatory relief | Strong |
| Technology / Software | $820K | 4–7× | Data privacy, antitrust, federal contracts | Strong |
| Healthcare (non-pharma) | $1.1M | 4–6× | Reimbursement rates, licensing, funding | Moderate |
| Agriculture & Food | $680K | 3–6× | Subsidies, trade policy, USDA programs | Moderate |
| Real Estate & Construction | $390K | 3–5× | Zoning, tax incentives, HUD programs | Moderate |
| Education / EdTech | $310K | 3–5× | Federal grants, state adoption, accreditation | Moderate |
| Transportation & Logistics | $540K | 3–5× | Infrastructure funding, regulatory standards | Moderate |
| Retail & Consumer | $210K | 2–4× | Tax policy, labor regulation, trade | Lower |
| Non-profit & Associations | $175K | 2–4× | Grant funding, tax exemptions, policy | Lower |